[
  {
    "ts": null,
    "headline": "1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 9.2%. This performance was worse than the S&P 500’s 1.8% loss.",
    "url": "https://finnhub.io/api/news?id=4b1ad6cccb57bddc1e5c683aaedb58ee68bf92ff328a441dd349a0ee74e0e855",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742562166,
      "headline": "1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down",
      "id": 133327473,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ALGN",
      "source": "Yahoo",
      "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 9.2%. This performance was worse than the S&P 500’s 1.8% loss.",
      "url": "https://finnhub.io/api/news?id=4b1ad6cccb57bddc1e5c683aaedb58ee68bf92ff328a441dd349a0ee74e0e855"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Equity  Opportunities Fund Q4 2024 Commentary",
    "summary": "The Davenport Equity Opportunities Fund (DEOPX) closed the year with a 0.37% quarterly advance, resulting in a 9.72% gain for the year. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=fb437e06eb08308ae3575c3467418e1dae683bd858846749117828b39492083b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742560200,
      "headline": "The Davenport Equity  Opportunities Fund Q4 2024 Commentary",
      "id": 133307136,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
      "related": "ALGN",
      "source": "SeekingAlpha",
      "summary": "The Davenport Equity Opportunities Fund (DEOPX) closed the year with a 0.37% quarterly advance, resulting in a 9.72% gain for the year. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=fb437e06eb08308ae3575c3467418e1dae683bd858846749117828b39492083b"
    }
  }
]